Abaloparatide in Postmenopausal Women With Osteoporosis and Type 2 Diabetes: A Post Hoc Analysis of the ACTIVE Study

Type 2 diabetes mellitus (T2DM) increases fracture risk despite normal or increased BMD. Abaloparatide reduces fracture risk in patients with postmenopausal osteoporosis (PMO); however, its efficacy in women with T2DM is unknown. This post hoc analysis evaluated the efficacy and safety of abaloparat...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhaliwal, Ruban, Hans, Didier, Hattersley, Gary, Mitlak, Bruce, Fitzpatrick, Lorraine A, Wang, Yamei, Schwartz, Ann V, Miller, Paul D, Josse, Robert G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117849/
https://www.ncbi.nlm.nih.gov/pubmed/32258965
http://dx.doi.org/10.1002/jbm4.10346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117849/
https://www.ncbi.nlm.nih.gov/pubmed/32258965
http://dx.doi.org/10.1002/jbm4.10346

Ejemplares similares